Physiotherapy Evidence Database - LANCET SERIES ON LOW BACK PAIN An excellent series of three papers on the global impact of non-specific low back pain was published in The Lancet on 20
Physio Meets Science on X: "The Lancet Series call to action to reduce low value care for low back pain: an update 👀❗️👀❗️ https://t.co/n0QL5QaB25 https://t.co/aRWDrtJFa0" / X
Low back pain of disc, sacroiliac joint, or facet joint origin: a diagnostic accuracy systematic review - eClinicalMedicine
![PDF] Prevention and treatment of low back pain: evidence, challenges, and promising directions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a6471a82be8bdec2419de2bcf5ecea79533fff42/3-Table2-1.png "PDF] Prevention and treatment of low back pain: evidence, challenges, and promising directions | Semantic Scholar")
PDF] Prevention and treatment of low back pain: evidence, challenges, and promising directions | Semantic Scholar
LANCET RENEWS CALLS FOR ACTION ON LBP - European Chiropractors' Union
Low Back Pain and the Brain — Trifecta Therapeutics Sports Rehabilitation & Performance Center
Low back pain
Over 800 million people globally may suffer back pain by 2050: Lancet study - DailyExcelsior
What low back pain is and why we need to pay attention - The Lancet
Cognitive functional therapy versus usual care for chronic, disabling low back pain
The Importance of Physical Therapy Treatment for Lower Back Pain - Northern Rehabilitation Physical Therapy Specialists
Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial - The Lancet
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial - The Lancet
More than 1 in 10 worldwide suffer lower back pain
The Lancet, 03 June 2023, Volume 401, Issue 10391, Pages 1825-1902
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial - The Lancet
The Lancet's call to action on low-back pain treatment
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial - The Lancet
Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 - The Lancet Rheumatology
What low back pain is and why we need to pay attention - The Lancet
Low back pain: a major global challenge - The Lancet
Low back pain | Nature Reviews Disease Primers
Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 - The Lancet Rheumatology
